GLUE
Monte Rosa·NASDAQ
--
--(--)
--
--(--)
5.60 / 10
Netural
Monte Rosa Therapeutics shows average fundamental strength: positive cash flow relative to market value and an excellent inventory turnover ratio are offset by a low net profit margin and suboptimal current assets turnover. The fundamental score of 5.6/10 aligns with a balanced rating, implying that while the company manages liquidity well, profitability and asset utilization remain areas for improvement. Historical factor performance suggests limited near-term upside from fundamentals alone.
Analysis Checks(6/10)
Revenue-MV
Value-1.73
Score3/3
Weight32.53%
1M Return20.82%
Value-1.73
Score3/3
Weight32.53%
1M Return20.82%
Gross profit margin (%)
Value100.00
Score3/3
Weight12.69%
1M Return10.80%
Value100.00
Score3/3
Weight12.69%
1M Return10.80%
PB-ROE
Value-0.06
Score1/3
Weight8.73%
1M Return7.02%
Value-0.06
Score1/3
Weight8.73%
1M Return7.02%
Fixed assets turnover ratio
Value2.22
Score2/3
Weight0.12%
1M Return0.12%
Value2.22
Score2/3
Weight0.12%
1M Return0.12%
Cash-MV
Value1.78
Score2/3
Weight9.47%
1M Return7.73%
Value1.78
Score2/3
Weight9.47%
1M Return7.73%
Inventory turnover ratio
Value47.85
Score3/3
Weight5.55%
1M Return5.26%
Value47.85
Score3/3
Weight5.55%
1M Return5.26%
Profit-MV
Value-0.40
Score3/3
Weight20.19%
1M Return12.18%
Value-0.40
Score3/3
Weight20.19%
1M Return12.18%
Current assets turnover ratio
Value0.31
Score1/3
Weight-0.48%
1M Return-0.48%
Value0.31
Score1/3
Weight-0.48%
1M Return-0.48%
Asset-MV
Value-0.50
Score1/3
Weight11.46%
1M Return8.74%
Value-0.50
Score1/3
Weight11.46%
1M Return8.74%
Net profit / Total profit (%)
Value118.20
Score0/3
Weight-0.28%
1M Return-0.30%
Value118.20
Score0/3
Weight-0.28%
1M Return-0.30%
Revenue-MV
Value-1.73
Score3/3
Weight32.53%
1M Return20.82%
Value-1.73
Score3/3
Weight32.53%
1M Return20.82%
Inventory turnover ratio
Value47.85
Score3/3
Weight5.55%
1M Return5.26%
Value47.85
Score3/3
Weight5.55%
1M Return5.26%
Gross profit margin (%)
Value100.00
Score3/3
Weight12.69%
1M Return10.80%
Value100.00
Score3/3
Weight12.69%
1M Return10.80%
Profit-MV
Value-0.40
Score3/3
Weight20.19%
1M Return12.18%
Value-0.40
Score3/3
Weight20.19%
1M Return12.18%
PB-ROE
Value-0.06
Score1/3
Weight8.73%
1M Return7.02%
Value-0.06
Score1/3
Weight8.73%
1M Return7.02%
Current assets turnover ratio
Value0.31
Score1/3
Weight-0.48%
1M Return-0.48%
Value0.31
Score1/3
Weight-0.48%
1M Return-0.48%
Fixed assets turnover ratio
Value2.22
Score2/3
Weight0.12%
1M Return0.12%
Value2.22
Score2/3
Weight0.12%
1M Return0.12%
Asset-MV
Value-0.50
Score1/3
Weight11.46%
1M Return8.74%
Value-0.50
Score1/3
Weight11.46%
1M Return8.74%
Cash-MV
Value1.78
Score2/3
Weight9.47%
1M Return7.73%
Value1.78
Score2/3
Weight9.47%
1M Return7.73%
Net profit / Total profit (%)
Value118.20
Score0/3
Weight-0.28%
1M Return-0.30%
Value118.20
Score0/3
Weight-0.28%
1M Return-0.30%
Is GLUE undervalued or overvalued?
- GLUE scores 5.60/10 on fundamentals and holds a Fair valuation at present. Backed by its 3.20% ROE, 11.54% net margin, 71.16 P/E ratio, 6.06 P/B ratio, and 117.98% earnings growth, these metrics solidify its Netural investment rating.
